Daniel A. Haber is the director of the Massachusetts General Hospital Cancer Center, a professor of oncology at Harvard Medical School, and an investigator of the Howard Hughes Medical Institute (HHMI).
and Ph.D. in biophysics from Stanford University School of Medicine under the mentorship of Robert T.
[1] He did his postdoctoral training at Massachusetts Institute of Technology with David E.
Sequencing the patient's cancers, they identified specific mutation in epidermal growth factor receptor (EGFR) that resulted in sensitivity to certain drugs.
[1] His lab is now focused on studying the genetics of cancer particularly in circulating tumor cells with Mehmet Toner.